Regeneron Genetics Center as a target discovery engine
The guest highlighted Regeneron Genetics Center (RGC) as a key technology platform, using large-scale patient sequencing linked to health records to discover genetic targets for new drugs.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.